Skip to main content
. 2025 Jan 2;15:150. doi: 10.1038/s41598-024-84600-z

Table 3.

Comparison of characteristics between the two groups after one week of treatment.

Variable Control group
(n = 56)
SV group
(n = 46)
P value
Heart rates(/min) 85 ± 13 86 ± 14 0.7187
Body temperature (℃) 36.8(36.7,37.2) 36.9(36.7,37.2) 0.8525
Breath rates(/min) 16(15,18) 17(15,18) 0.2337
Serum lipase (IU/ml) 58.6(30.1,90.8) 51.3(31.2,84.4) 0.5607
Serum amylase (IU/ml) 41.5(28.3,68.0) 44.5(31.0,72.0) 0.8532
WBC count (×109/L) 10.33(7.70,13.23) 10.27(8.50,12.77) 0.9759
PCT (ng/L) 0.785(0.328,1.749) 0.984(0.363,2.487) 0.6965
IL-6 (pg/ml) 48.01(21.37,101.4) 36.87(19.06,82.28) 0.2366
IL-10 (pg/ml) 2.63(1.60,4.72) 2.62(1.55,4.78) 0.9063
TNF-α (pg/ml) 1.78(1.15,2.76) 1.52(1.06,2.55) 0.2834
Urine volume (ml/h) 107(84,160) 120(81,151) 0.5974
Scr (µmol/L) 65.5(51.0,89.0) 79.0(58.8,97.5) 0.0531
BUN (mmol/L) 3.66(2.78,5.29) 3.85(3.143,6.00) 0.5813

Proportion of patients

recovering from AKI

9/21(42.86%) 17/22(77.27%) 0.0305

The proportion of

patients with restored

bowel sounds

7/23(30.43%) 15/24(62.50%) 0.0415
Oxygenation index 287 ± 72 290 ± 91 0.8309

WBC, white blood cell; PCT, procalcitonin; Scr, serum creatinine; BUN, blood urea nitrogen; AKI, acute kidney injury; CRRT, continuous renal replacement therapy. Measurement data conformed to normal distribution are presented as the means ± SD, and the skewness distribution with median (quartile). Counting data is expressed as m/n (%). P < 0.05 indicates a statistically significant difference. Significant values are in italics.